Therapixel mammoscreen

Therapixel Receives FDA Clearance for AI-Based Breast Cancer Screening Software MammoScreen® on 3D Mammography

Therapixel has announced it has received a second 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its explainable and actionable Artificial Intelligence (A.I.) based software assisting Radiologists in breast cancer screening, MammoScreen®. This new 510(k) (K211541) expands the use of Mammoscreen® to Digital Breast Tomosynthesis (or 3D Mammography).

Babyscripts Virtual Maternity Care Funding

Babyscripts Raises Additional $7.5M for Virtual Maternity Care National Expansion

Maternal health startup Babyscripts, which makes an app for expectant mothers, has raised another $7.5 million in a Series B round. This additional funding brings this latest haul to $19.5 million, after the $12 million it secured in September. Babyscripts expects to use this extra funding to continue building out its platform, Babyscripts Virtual Maternity Care, a tool that tracks a patient’s pregnancy and postpartum information at each stage.